首页 | 官方网站   微博 | 高级检索  
     

自身免疫性甲状腺疾病和CD4~+CD25~+调节性T细胞
引用本文:侍晓云,赵勇.自身免疫性甲状腺疾病和CD4~+CD25~+调节性T细胞[J].国际内分泌代谢杂志,2010,30(Z1).
作者姓名:侍晓云  赵勇
作者单位:武警总医院内分泌科,北京,100039
摘    要:自身免疫性甲状腺疾病(AITD)的发生及发展与CD4~+CD25~+调节性T细胞(Treg细胞)的数量和功能密切相关.动物实验证明Treg细胞可抑制AITD的发生.如果清除动物体内的该类细胞,可导致AITD发病或使原有的甲状腺疾病加重,Treg细胞通过抑制效应性T细胞的激活而发挥对AITD的影响作用.无论是胸腺还是外周,不同诱导体系来源的Treg细胞均对AITD有影响作用.

关 键 词:自身免疫性甲状腺疾病  CD4~+CD25~+调节性T细胞

Autoimmune thyroid disease and CD4~+ CD25~+ regulatory T cell
SHI Xiao-yun,ZHAO Yong.Autoimmune thyroid disease and CD4~+ CD25~+ regulatory T cell[J].International JOurnal of Endocrinology and Metabolism,2010,30(Z1).
Authors:SHI Xiao-yun  ZHAO Yong
Abstract:The occurance and development of autoimmune thyroid disease (AITD)is related with changes of quantities and function of CD4~+CD25~+ regulatory T(Treg) cells. Different studies indicated that Treg cells can inhibit the development of AITD. Depletion of Treg cells can improve the incidence of AITD or increase the severity of AITD. Treg cells play roles in inhibiting activation of effector T cell. No matter Treg cells or CD4~+ CD25~+ regulatory T cells generated in the periphery can influence the development of AITD.
Keywords:Autoimmune thyroid disease  CD4~+ CD25~+ regulatory T cells
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号